Home > Healthcare > Pharmaceuticals > Finished Drug Form > Precision Medicine Market

Precision Medicine Market Size

  • Report ID: GMI671
  • Published Date: Apr 2024
  • Report Format: PDF

Precision Medicine Market Size

Precision Medicine Market size accounted for around USD 79.9 billion revenue size in 2023 and is projected to witness significant growth at 7.6% CAGR between 2024 to 2032. One of the primary drivers is the increasing prevalence of chronic diseases, such as cancer, cardiovascular diseases, and diabetes. These conditions require tailored treatments, and precision medicine offers personalized approaches based on individual genetic, environmental, and lifestyle factors.

 

Further, advancements in genomics and molecular biology have also accelerated the growth of precision medicine by enabling more precise and cost-effective genetic testing. Moreover, government initiatives and funding support have also played a significant role in driving the expansion of the precision medicine market.
 

Precision medicine, also known as personalized medicine or individualized medicine, is an approach to healthcare that takes into account individual differences in genes, environment, and lifestyle when designing medical treatment plans and interventions. Rather than applying a one-size-fits-all approach, precision medicine aims to tailor medical decisions and treatments to the specific characteristics of each patient.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global precision medicine industry size was USD 79.9 billion in 2023 and is projected to witness 7.6% CAGR between 2024 to 2032, driven by the increasing prevalence of chronic diseases, such as cancer, cardiovascular diseases, and diabetes.

The therapeutic segment held 58.7% of the market share in 2023, owing to the growing focus on developing targeted therapies tailored to individual patient characteristics.

North America precision medicine market size will record 7.5% CAGR during 2024-2032, attributed to the well-established network of hospitals, research institutions, and diagnostic laboratories.

Abbott Laboratories, Inc., Abbvie, Inc., AstraZeneca plc, bioMerieux SA, Bristol-Myers Squibb Company, Cepheid (Danaher Corporation), Eli Lilly & Company, F. Hoffmann-La Roche, GlaxoSmithKline plc, Laboratory Corporation of America Holdings (Covance Inc.), Myriad Genetics, Inc. and Novartis AG

Precision Medicine Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 18
  • Tables & Figures: 407
  • Countries covered: 22
  • Pages: 234
 Download Free Sample